Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects

Cardiotoxicity and BTK Inhibitors: What CLL Patients Should Know
Apr 16, 2025
05:00PM - 06:00PM EDT
Online Event
Dr. Kerry Rogers will be speaking to the HealthTree Chronic Lymphocytic Leukemia community about BTK Inhibitors and their cardiotoxicity. Join us for this webinar to learn more about this important topic!
Agenda
5:00 PM
Introduction
Dalton Bean
Dalton introduces the agenda of the event and featured speaker Dr. Kerry Rogers
5:05 PM
Presentation
Kerry Rogers, MD
Dr. Rogers talks about BTK Inhibitors and their cardiotoxicity.
5:35 PM
Questions and Answers
Audience
Type your questions in the chat, we will answer them!

Dalton Bean

Kerry Rogers, MD